EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Micro‐Needle Assisted Transmucosal Delivery of Triamcinolone and Hyaluronic Acid for the Treatment of Oral Lichen Planus: A Randomized Clinical Trial

Maryam Zahed iD, Mostafa Rezaee iD, Asma Sookhakian iD, Mozhdeh Sepaskhah

Oral Diseases · 2026

DOI: 10.1111/odi.70226 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, 2026. Verfasst von Maryam Zahed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oral and Dental Disease Research Center, Department of Oral and Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, S…. Hauptthemen laut MEDLINE: Glucocorticoids, Hyaluronic Acid, Lichen Planus, Oral, Microneedle Drug Delivery. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The atrophic‐erosive forms of oral lichen planus (OLP) remain a major concern as these lesions can cause a wide range of symptoms leading to reduced quality of life. Nowadays, newer possibilities are offered by micro‐needles as an effective transmucosal drug delivery. The aim of this single‐blinded randomized clinical trial was to determine the therapeutic efficacy of micro‐needling (MN) as a novel technique for transmucosal delivery of triamcinolone acetonide (TA) and hyaluronic acid (HA) on symptomatic OLP lesions.

Methods

Twenty volunteers with bilateral symptomatic OLP lesions were randomly assigned to the study involving four different treatment groups (G): G 1 , topical TA alone; G 2 , MN as an adjunct to the topical TA; G 3 , topical TA and HA; and G 4 , MN as an adjunct to the topical TA and HA. Lesions were assessed at baseline, and on Days 7, 14, 28, and 56 using parameters including the percentage healing index (PHI), reticulation/erythema/ulceration (REU) score, and visual analogue scale (VAS). Statistical analysis was then performed using SPSS software.

Results

Twenty patients (40 lesions; 10 per group) were included. G 4 showed a significantly higher PHI compared to both G 1 ( p 0.001) and G 3 ( p < 0.05) at all observation times. Regarding the REU score, G 4 achieved significantly greater reductions compared to G 1 at all observation times ( p < 0.05), compared to G 2 on Days 7, 28, and 56 ( p < 0.05), and compared to G 3 on Days 28 and 56 ( p < 0.05). Regarding the VAS, both G 2 and G 4 showed a statistically significant reduction on Day 7 compared to G 1 and G 3 ( p < 0.05).

Conclusion

This study uncovered the advantages of MN in promoting healing, reducing severity, and alleviating pain in OLP patients. Therefore, MN has the potential to become an effective and well‐tolerated treatment modality for symptomatic OLP. Moreover, the adjunctive use of MN with topical application of both TA and HA demonstrated the most significant therapeutic benefits, suggesting a synergistic effect. Trial Registration irct.behdasht.gov.ir : IRCT20231213060357N1 (17 February 2024)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsHyaluronic AcidLichen Planus, OralMicroneedle Drug DeliveryTriamcinolone AcetonideAdultAgedFemaleHumansMaleMiddle AgedAdministration, MucosalSingle-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

drug delivery systemshyaluronic acidoral lichen planustriamcinolone acetonide

Substanzen

GlucocorticoidsHyaluronic AcidTriamcinolone Acetonide

Autor:innen und Institutionen

  • Oral and Dental Disease Research Center, Department of Oral and Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Dermatology, School of Medicine, Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

ORCID-Profile: Maryam Zahed, Mostafa Rezaee, Asma Sookhakian

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Zahed, M., Rezaee, M., Sookhakian, A., & Sepaskhah, M. (2026). Micro‐Needle Assisted Transmucosal Delivery of Triamcinolone and Hyaluronic Acid for the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Oral Diseases. https://doi.org/10.1111/odi.70226

Vancouver

Zahed M, Rezaee M, Sookhakian A, Sepaskhah M. Micro‐Needle Assisted Transmucosal Delivery of Triamcinolone and Hyaluronic Acid for the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Oral Diseases. 2026. doi:10.1111/odi.70226

BibTeX
@article{Zahed2026,
  author = {Zahed, Maryam and Rezaee, Mostafa and Sookhakian, Asma and Sepaskhah, Mozhdeh},
  title = {Micro‐Needle Assisted Transmucosal Delivery of Triamcinolone and Hyaluronic Acid for the Treatment of Oral Lichen Planus: A Randomized Clinical Trial},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70226}
}
Kostenlos starten →